Ablynx Nv Ads





Please Login or Register

Login|Register FREE

Stock Price
Open: 52.96
Prev. Close: 52.80
Low/Hi: 52.67 - 52.97
52-Week: 17.75 - 55.29
Equity: 9,775
90-Day Avg: 260,092
Option: 12
90-Day Avg: 719
Todays Stock Vol: 7.1
20-Day (HV): 11.9
52-Week (HV): 27.9
30-Day IV: 6.9 +0.8
IV Pct Rank: 2% Subdued
Div. Yield:
Earnings: 30-Aug
P/E Ratio:
Market Cap: 4.1 B
Short Int Pct: 0.0%
Pct Held By Inst.: 22.8%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ABLX

Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments. The Company has approximately 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)

ABLX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
MRGR ProShares Merger ETF 4.4 M 4413790 51 51 3.47% 0.0347444 109 K 108882

Wait, Before You Leave...

Want to Know More About ABLX Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon